Caution

Please find SDS provided by EDQM here..

General description

Methyl nicotinate is a potent vasodilatory drug capable of transdermal penetration. It is known to elicit distinctive erythema through the production of prostaglandin D2(PGD2) and beneficial for the treatment of respiratory, vascular and rheumatoid disorders.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

Packaging

Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.